Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma

(2017) Andrea M. Abbott et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Metastatic disease from uveal melanoma: treatment options and future prospects

(2016) Richard D Carvajal et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

(2016) Alain P. Algazi et al.   CANCER

Overall Survival and Durable Responses in Patients WithBRAFV600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib

(2016) Georgina V. Long et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

(2016) Ioannis Karydis et al.   OncoImmunology

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

(2015) Marybeth S. Hughes et al.   ANNALS OF SURGICAL ONCOLOGY

Uveal Melanoma UK National Guidelines

(2015) P. Nathan et al.   EUROPEAN JOURNAL OF CANCER

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

(2015) Lisa Zimmer et al.   PLoS One

The biology and treatment of oligometastatic cancer

(2015) Diane K. Reyes et al.   Oncotarget

Intra-arterial infusion and chemo-embolization for melanoma liver metastases

(2014) Suhrid Lodh et al.   JOURNAL OF SURGICAL ONCOLOGY

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

(2013) Sander Kelderman et al.   ACTA ONCOLOGICA

Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

(2013) Sanjiv S. Agarwala et al.   CANCER

The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection

(2013) D. Gomez et al.   JOURNAL OF SURGICAL ONCOLOGY

Isolated hepatic perfusion for metastatic melanoma

(2013) Maki Yamamoto et al.   JOURNAL OF SURGICAL ONCOLOGY

Immunotherapeutic modulation of the suppressive liver and tumor microenvironments

(2011) Tim Chan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER